Meanwhile, in Mississippi…

The Mississippi Board of Nursing has issued a temporary rule regarding GLP-1 treatment that included a provision related to compounding. 

If any compounded medication is administered or prescribed, it says, the licensee (i.e., the nurse) shall confirm the pharmacy supplying the compounded medication has either… 

• obtained the active pharmaceutical ingredient (API) from a US-based repackager or wholesaler that has performed API verification testing to confirm the supplied certificate of analysis (COA), or
• that pharmacy has independently performed API verification testing to confirm the supplier’s COA

The rule is currently effective, but the requirements only last through May 30, 2025.

(Oh, and by the way: We suspect a certain drugmaker is behind this move.)

While we’re talking about the Magnolia State … a bill there that would have provided that vitamins administered by a nurse through IV therapy in a clinical setting did not have to be prepared by a compounding pharmacy. It died in committee. RIP.